Stocks · Health care · Pharmaceutical Preparations

ENANTA PHARMACEUTICALS INC

ENTA Clue Score19

United States Fiscal year ends September CIK 0001177648 Results filed 10 Aug 2026

Add to watchlist

What the insiders did Net selling

By person

15 insiders · 158 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Nathalie Adda

Sr. VP & Chief Medical Officer

—

$15.32M (43) scheduled

−$15.32M

34,982

0.1201%

$497.79K

+3,831%

Jay R. Luly

President and CEO

$256.05K (1)

$10.08M (17)

−$9.82M

871,871

2.99%

$12.41M

+34.0%

Yat Sun Or

Chief Scientific Officer

—

$5.70M (14) scheduled

−$5.70M

374,854

1.29%

$5.33M

+13.7%

Paul J Mellett

Chief Fin. & Admin Officer

—

$4.25M (18)

−$4.25M

95,884

0.3292%

$1.36M

+667.6%

George Golumbeski

Director

—

$2.18M (3) scheduled

−$2.18M

0

0.0000%

$0.00

—

Tim Ocain

Senior Vice President

—

$2.09M (4) scheduled

−$2.09M

17,547

0.0602%

$249.69K

—

Bruce L A Carter

Director

—

$1.26M (7) scheduled

−$1.26M

0

0.0000%

$0.00

—

Nathaniel S. Gardiner

Chief Legal Officer

—

$334.79K (2)

−$334.79K

108,978

0.3742%

$1.55M

—

Scott T. Rottinghaus

Chief Medical Officer

—

$214.22K (6) scheduled

−$214.22K

23,787

0.0817%

$338.49K

—

Tara Lynn Kieffer

Chief Product Strategy Officer

—

$158.42K (4) scheduled

−$158.42K

33,925

0.1165%

$482.75K

—

Terry Vance

Director

—

$139.49K (1)

−$139.49K

5,800

0.0199%

$82.53K

−62.1%

Brendan Luu

Chief Business Officer

—

$58.70K (3)

−$58.70K

41,634

0.1429%

$592.45K

—

Harry R. Trout III

See Remarks

—

$13.02K (2)

−$13.02K

16,348

0.0561%

$232.63K

+49.8%

Kathleen S. Capps

See Remarks

—

$7.49K (2)

−$7.49K

8,377

0.0288%

$119.20K

+43.7%

Matthew Paul Kowalsky

Chief Legal Officer

—

—

—

3,591

0.0123%

$51.10K

—